Global Investigational New Drug Cdmo Market Size & Outlook
The investigational new drug cdmo industry worldwide is expected to reach a projected revenue of US$ 6,806.0 million by 2028. A compound annual growth rate of 6.9% is expected of the worldwide investigational new drug cdmo industry from 2022 to 2028.
Revenue, 2021 (US$M)
$4,277.5
Forecast, 2028 (US$M)
$6,806.0
CAGR, 2022 - 2028
6.9%
Report Coverage
Worldwide
Global investigational new drug cdmo market, 2018-2028 (US$M)
Related Markets
Global investigational new drug cdmo market highlights
- The global investigational new drug cdmo market generated a revenue of USD 4,277.5 million in 2021 and is expected to reach USD 6,806.0 million by 2028.
- The market is expected to grow at a CAGR (2022 - 2028) of 6.9% by 2028.
- In terms of segment, small molecule accounted for a revenue of USD 3,798.6 million in 2021.
- Large Molecule is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, UAE is expected to register the highest CAGR from 2022 to 2028.
Global data book summary
| Market revenue in 2021 | USD 4,277.5 million |
| Market revenue in 2028 | USD 6,806.0 million |
| Growth rate | 6.9% (CAGR from 2021 to 2028) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, the North America accounted for 41.1% of the global investigational new drug cdmo market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
- By country, UAE is the fastest growing regional market and is projected to reach USD 26.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Investigational New Drug CDMO Market Scope
Investigational new drug cdmo market segmentation & scope
Bioanalysis and DMPK studies
Toxicology Testing
Pathology and safety pharmacology studies
Drug substance synthetic route development
Drug substance process development
Form selection crystallization process development
Scale-up of drug substance
Preformulation
Preclinical formulation selection
First in Man Formulation/ Process Development
Analytical method development / validation
Release testing of drug substance and drug product
Work up Purification Steps
Telescoping & Process Refining
Initial Optimization
Formal stability of drug substance and drug product
Cell Line development
Microbial
Mammalian
Others
MABs
Recombinant proteins
Others
Oral Solids
Liquid and Semi-solids
Injectables
Others
MABs
Recombinant proteins
Others
Investigational New Drug CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global investigational new drug cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to investigational new drug cdmo market will help companies and investors design strategic landscapes.
small molecule was the largest segment with a revenue share of 88.8% in 2021. Horizon Databook has segmented the Global investigational new drug cdmo market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2028.
- Global Investigational New Drug CDMO Product Outlook (Revenue, USD Million, 2018-2028)
- Small Molecule
- Large Molecule
- Global Investigational New Drug CDMO Services Outlook (Revenue, USD Million, 2018-2028)
- Contract Development
- Small Molecule
- Bioanalysis and DMPK studies
- Toxicology Testing
- Pathology and safety pharmacology studies
- Drug substance synthetic route development
- Drug substance process development
- Form selection crystallization process development
- Scale-up of drug substance
- Preformulation
- Preclinical formulation selection
- First in Man Formulation/ Process Development
- Analytical method development / validation
- Release testing of drug substance and drug product
- Work up Purification Steps
- Telescoping & Process Refining
- Initial Optimization
- Formal stability of drug substance and drug product
- Large Molecule
- Cell Line development
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- MABs
- Recombinant proteins
- Others
- Upstream
- Small Molecule
- Contract Manufacturing
- Small Molecule
- Oral Solids
- Liquid and Semi-solids
- Injectables
- Others
- Large Molecule
- MABs
- Recombinant proteins
- Others
- Small Molecule
- Contract Development
- Global Investigational New Drug CDMO End Use Outlook (Revenue, USD Million, 2018-2028)
- Pharmaceutical Companies
- Small
- Medium
- Large
- Biotech Companies
- Others
- Pharmaceutical Companies
Reasons to subscribe to Global investigational new drug cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global investigational new drug cdmo market databook
-
Our clientele includes a mix of investigational new drug cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global investigational new drug cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global investigational new drug cdmo market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Global investigational new drug cdmo market statistics, by regions, 2018-2028 (US$M)
Top 10 countries: Investigational new drug cdmo market size, 2021 (USD Million)
Top 10 countries: Investigational new drug cdmo market size, 2021 (USD Million)
Global investigational new drug cdmo market, by region, 2021 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
